Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Solid Tumor × mogamulizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

apatinib 3 Injections 3 toripalimab 2 alpha-Synuclein 2 Drug Therapy 2 Docetaxel 2 Cisplatin 2 Capecitabine 2 trametinib 1 tislelizumab 1 tesetaxel 1 surufatinib 1 spartalizumab 1 pyrotinib 1 pemigatinib 1 pembrolizumab 1 nimotuzumab 1 mogamulizumab 1 irinotecan sucrosofate 1 famitinib 1 dalpiciclib 1 camrelizumab 1 YM753 compound 1 Vemurafenib 1 SHR-1701 1 Radiotherapy 1 Radiosurgery 1 Radiation 1 Pemetrexed 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01929486 2016-02-17

Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer.

Aichi Medical University

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡